TQVAX | VIVIX | TQVAX / VIVIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 26 years | - |
Gain YTD | 16.511 | 16.286 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 40M | 183B | 0% |
Annual Yield % from dividends | 0.39 | 2.37 | 16% |
Returns for 1 year | 19.01 | 24.01 | 79% |
Returns for 3 years | 23.24 | 28.27 | 82% |
Returns for 5 years | 49.49 | 55.47 | 89% |
Returns for 10 years | N/A | 114.02 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FNIAX | 41.54 | -0.02 | -0.05% |
Fidelity Advisor New Insights A | |||
CRFAX | 11.86 | -0.02 | -0.17% |
Calvert Focused Value A | |||
INDZX | 17.53 | -0.06 | -0.35% |
Columbia Large Cap Value A | |||
RLECX | 24.13 | -0.25 | -1.03% |
Russell Inv US Small Cap Equity C | |||
WCMSX | 21.47 | -0.28 | -1.29% |
WCM International Small Cap Growth Instl |